Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients

Objective: The present study assesses whether phosphodiesterase type 5 (PDE-5) inhibitor or carnitine exert nephroprotective effects against clinical contrast-induced nephropathy (CIN). Materials and Methods: The present study consisted of three groups of CKD patients. The first group was control gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Armaly, Zaher, Artol, Suheil, Jabbour, Adel R., Saffouri, Amer, Habashi, Nayef, Abd Elkadir, Amir, Ghattas, Naser, Farah, Raymond, Kinaneh, Safa, Nseir, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913644/
https://www.ncbi.nlm.nih.gov/pubmed/31797710
http://dx.doi.org/10.1080/0886022X.2019.1669459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913644/
https://www.ncbi.nlm.nih.gov/pubmed/31797710
http://dx.doi.org/10.1080/0886022X.2019.1669459

Ejemplares similares